National HealthCare Corp (NHC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:National HealthCare Corp (NHC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5149
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National HealthCare Corp (NHC) is a health care service provider that offers home-care and assisted living services. The center offers rehabilitative care, skilled nursing, Alzheimer’s and memory care, residential and assisted living, home care, hospice care and long term care insurance services. It offers home care services such as infusion therapy, wound care, and physical, occupational, speech therapies and rehabilitation services. NHC offers education, support and counseling to the families and caregivers of patients. The center also offers management and accounting services. It operates through its medical centers, residential living centers and assisted living communities. The center operates its homecare licensed and Medicare-certified offices in four states such asTennessee, South Carolina, Missouri and Florida, the US. NHC is headquartered in Murfreesboro, Tennessee, the US.

National HealthCare Corp (NHC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
National HealthCare Corp, Pharmaceuticals & Healthcare, Deal Details 9
Asset Purchase 9
National HealthCare Completes Acquisition Of Six HealthCare Centers From National Health Investors For US$21 Million 9
Partnerships 11
National HealthCare Enters Into Joint Venture Agreement With TriStar Health System 11
Acquisition 12
Caris Healthcare Acquires Solaris Hospice From National HealthCare 12
National HealthCare Corp – Key Competitors 13
National HealthCare Corp – Key Employees 14
National HealthCare Corp – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 19
Financial Announcements 19
Feb 20, 2018: NHC Reports Year End Earnings 19
Aug 04, 2017: NHC Reports Second Quarter Earnings 20
May 10, 2017: NHC Reports First Quarter Earnings 21
Feb 15, 2017: NHC Reports Year End Earnings 22
Corporate Communications 23
Feb 13, 2017: NHC Announces New Chief Information Officer 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
National HealthCare Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National HealthCare Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
National HealthCare Completes Acquisition Of Six HealthCare Centers From National Health Investors For US$21 Million 9
National HealthCare Enters Into Joint Venture Agreement With TriStar Health System 11
Caris Healthcare Acquires Solaris Hospice From National HealthCare 12
National HealthCare Corp, Key Competitors 13
National HealthCare Corp, Key Employees 14
National HealthCare Corp, Other Locations 15
National HealthCare Corp, Subsidiaries 16

List of Figures
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
National HealthCare Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[National HealthCare Corp (NHC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Avantec Vascular Corp:企業の製品パイプライン分析2018
    Summary Avantec Vascular Corp (Avantec Vascular), a subsidiary of Goodman Co Ltd, is a medical device company that develops cardiovascular interventional and peripheral vascular devices. The company's products comprise balloon catheter, aspiration catheter, device delivery system, micro catheter, gu …
  • SynGen Inc-医療機器分野:企業M&A・提携分析
    Summary SynGen Inc (SynGen) is a medical device company that develops and markets cell separation tools and accessories. The company’s products comprise SynGenX series platform and auxiliary products such as CryoPRO workstation, transfer workstation and sterile docking workstations. Its SynGenX-Seri …
  • Steris PLC:企業の戦略・SWOT・財務情報
    Steris PLC - Strategy, SWOT and Corporate Finance Report Summary Steris PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Societe Generale S.A.:企業の戦略・SWOT・財務分析
    Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report Summary Societe Generale S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • UPM-Kymmene Corporation:企業の戦略・SWOT・財務情報
    UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report Summary UPM-Kymmene Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Green Energy Technology Inc Ltd (3519):電力:M&Aディール及び事業提携情報
    Summary Green Energy Technology Inc Ltd (Green Energy Technology), a subsidiary of Tatung Company is an alternative energy company that manufactures and markets multi-crystalline solar wafers. The company's products include single-crystalline wafer cuttings, thin film photovoltaic modules, multi-cry …
  • Molecular Warehouse Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Molecular Warehouse Ltd (Molecular Warehouse) is a developer of proteins for diagnostic and therapeutic use. The company helps prevent diseases by empowering people with molecular diagnostics. Its synthetic biology techniques enabled it to reengineer glucose dehydrogenase, and enzymes found …
  • Paramount Resources Ltd (POU):企業の財務・戦略的SWOT分析
    Summary Paramount Resources Ltd (Paramount Resources) is an energy company that offers exploration, production, development, and marketing of oil and gas products. The company offers products such s crude oil, fuel oil, natural gas and natural gas liquids. It operates in three segments such as princ …
  • China Medical System Holdings Ltd (867):製薬・医療:M&Aディール及び事業提携情報
    Summary China Medical System Holdings Ltd (CMS) is a pharmaceutical service provider that markets, promotes, and sells prescription drugs to all therapeutic departments in hospitals. The company offers products such as deanxit, ursofalk, augentropfen stulln mono eye-drops, exacin, xinhuosu, salofalk …
  • Pacific Textiles Holdings Ltd (1382):企業の財務・戦略的SWOT分析
    Pacific Textiles Holdings Ltd (1382) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Marvel Entertainment LLC:企業の戦略的SWOT分析
    Marvel Entertainment LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Sodra Skogsagarna ekonomisk forening:企業の戦略的SWOT分析
    Sodra Skogsagarna ekonomisk forening - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Scynexis Inc (SCYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Scynexis Inc (Scynexis) is a pharmaceutical company that discovers, develops and commercializes novel anti-infective for various therapeutic needs. The company provides pipeline products such as SCY-078, is used for invasive fungal infections; SCY-635, is used for the treatment of Hepatitis …
  • Pioneer Natural Resources Co (PXD):企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Rockhopper Exploration PLC (RKH):企業の財務・戦略的SWOT分析
    Summary Rockhopper Exploration Plc (Rockhopper Exploration) is an oil and gas company that acquires, explores and produces crude oil and natural gas properties in the Falkland Islands and the Greater Mediterranean region. The company’s portfolio of production licenses includes PL003a, PL003b, PL004a …
  • Rubicon Genomics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Rubicon Genomics Inc (Rubicon Genomics), a subsidiary of the Takara Bio Group is a provider of pre-analytical amplification technologies. The company offers various types of kits for whole genome sequencing (WGS), whole exome sequencing (WES), targeted sequencing, copy number variation (CNV) …
  • OpenWay Group:企業の戦略的SWOT分析
    OpenWay Group - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Aqua Bio Technology ASA (ABT):企業の財務・戦略的SWOT分析
    Summary Aqua Bio Technology ASA (ABT) is a biotechnology company that develops, produces and markets new active ingredients. The company’s products comprise Aquabeautine XL and Smids. Its product Aquabeautine XL is derived from the hatching fluid of salmon. ABT’s products are based on research and d …
  • AWE Ltd (AWE)-石油・ガス分野:企業M&A・提携分析
    Summary AWE Ltd (AWE) is an independent upstream oil and gas company. It focuses on the exploration, production and sale of oil, gas and condensate. The company has a diverse portfolio of upstream assets in Australia, New Zealand, and Indonesia. Its producing assets include BassGas project in Tasman …
  • Aspen Pharmacare Holdings Ltd (APN):企業の財務・戦略的SWOT分析
    Aspen Pharmacare Holdings Ltd (APN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆